🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT04421924
Recruiting Not applicable

Periinterventional Coagulation Management of Patients Undergoing a TIPS

NCT04421924 · tracked via the Priya Life Science Austria tracker
Phase
Not applicable
Started
2020-05-27
Last updated
2025-12-09

Condition(s) studied

Liver Cirrhosis

Investigational drug(s) / intervention(s)

thrombelastogramstandard of care

thrombelastogram: Patients in the TEG group will receive prothrombin complex concentrates (PCC) at a dose of 10 IE/kg of ideal body weight, when R-time was greater than 40 minutes (2400 sec) and they will receive platelet transfusion in the amount of 1 apheresis unit when MA was below 30 mm

standard of care: 2\) In the SOC group, patients will receive PCC at the dose of 10 IE /kg of ideal body weight when the PT is below 50% and/or INR\>1.8 and/or received platelet transfusion in the amount of 1 apheresis when platelet count is below 50 G/L

Study summary

Assess whether a pre-interventional thrombelastography guided algorithm for assessing and correction of coagulation status in cirrhotic patients is safe and effective

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
inclusion criteria * Liver cirrhosis * \>18 years * Indication for TIPS implantation * Ability to sign informed consent exclusion criteria * Contraindications against TIPS implantation * Hepatocellular carcinoma BCLC D * Ongoing bleeding * pre-existing anticoagulant therapy at time of inclusion * administration of blood products within 1 week prior to the enrolment * Other malignancies that lead to an impaired 90-day survival * Inherit blood clotting disorders * Hepatic encephalopathy grade 3 or 4 * any other condition or circumstance, which, in the opinion of the investigator, would affect the patient's ability to participate in the protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Internal Medicine, Medical University of Graz Graz Austria Recruiting

More Medical University of Graz trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04421924 on ClinicalTrials.gov ↗ ← All trials in Austria